Ivo Elezović

1.4k total citations
78 papers, 917 citations indexed

About

Ivo Elezović is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ivo Elezović has authored 78 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 16 papers in Genetics and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ivo Elezović's work include Platelet Disorders and Treatments (23 papers), Hemophilia Treatment and Research (17 papers) and Acute Myeloid Leukemia Research (15 papers). Ivo Elezović is often cited by papers focused on Platelet Disorders and Treatments (23 papers), Hemophilia Treatment and Research (17 papers) and Acute Myeloid Leukemia Research (15 papers). Ivo Elezović collaborates with scholars based in Serbia, Czechia and Sweden. Ivo Elezović's co-authors include Nada Suvajdžić, Mirjana Mitrović, Dragica Tomin, Ana Vidović, Darko Antić, Valentina Djordjević, Irena Đjunić, Andrija Bogdanović, Dragica Radojković and Predrag Miljić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Ivo Elezović

76 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivo Elezović Serbia 17 667 199 153 101 98 78 917
Carlo L. Balduini Italy 20 674 1.0× 181 0.9× 248 1.6× 99 1.0× 60 0.6× 52 1.1k
Micah J. Mooberry United States 13 308 0.5× 161 0.8× 153 1.0× 74 0.7× 117 1.2× 22 681
Ivan Budnik Israel 14 491 0.7× 72 0.4× 150 1.0× 86 0.9× 126 1.3× 64 763
Silvia Linari Italy 22 1.3k 1.9× 205 1.0× 388 2.5× 97 1.0× 68 0.7× 75 1.7k
Kathleen Jentsch‐Ullrich Germany 15 313 0.5× 140 0.7× 243 1.6× 80 0.8× 94 1.0× 46 882
Kenichi Ogiwara Japan 20 855 1.3× 62 0.3× 229 1.5× 115 1.1× 111 1.1× 95 1.1k
Eugenia Biguzzi Italy 18 540 0.8× 85 0.4× 120 0.8× 150 1.5× 207 2.1× 50 929
H F Kotzé South Africa 15 418 0.6× 50 0.3× 101 0.7× 125 1.2× 79 0.8× 39 779
Lisa Boggio United States 18 1.0k 1.6× 275 1.4× 431 2.8× 225 2.2× 360 3.7× 55 1.7k
Coralie Judicone France 10 236 0.4× 706 3.5× 63 0.4× 114 1.1× 133 1.4× 11 961

Countries citing papers authored by Ivo Elezović

Since Specialization
Citations

This map shows the geographic impact of Ivo Elezović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivo Elezović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivo Elezović more than expected).

Fields of papers citing papers by Ivo Elezović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivo Elezović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivo Elezović. The network helps show where Ivo Elezović may publish in the future.

Co-authorship network of co-authors of Ivo Elezović

This figure shows the co-authorship network connecting the top 25 collaborators of Ivo Elezović. A scholar is included among the top collaborators of Ivo Elezović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivo Elezović. Ivo Elezović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sørensen, Benny, Günter Auerswald, Gary Benson, et al.. (2014). Rationale for individualizing haemophilia care. Blood Coagulation & Fibrinolysis. 26(8). 849–857. 17 indexed citations
2.
Mitrović, Mirjana, Ivo Elezović, Danica Grujičić, Predrag Miljić, & Nada Suvajdžić. (2014). Complex haemostatic abnormalities as a cause of bleeding after neurosurgery in a patient with Gaucher disease. Platelets. 26(3). 260–262. 2 indexed citations
3.
Mitrović, Mirjana, Ivo Elezović, Predrag Miljić, & Nada Suvajdžić. (2013). Acquired von Willebrand syndrome in patients with Gaucher disease. Blood Cells Molecules and Diseases. 52(4). 205–207. 6 indexed citations
5.
Suvajdžić, Nada, Zorica Cvetković, Vesna Đorđević, et al.. (2012). Prognostic factors for therapy-related acute myeloid leukaemia (t-AML) – A single centre experience. Biomedicine & Pharmacotherapy. 66(4). 285–292. 4 indexed citations
6.
Mitrović, Mirjana, Darko Antić, Ivo Elezović, et al.. (2011). Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease. Platelets. 23(2). 143–149. 12 indexed citations
7.
Antić, Darko, et al.. (2010). Isolated Myeloid Sarcoma of the Gastrointestinal Tract. Internal Medicine. 49(9). 853–856. 17 indexed citations
8.
Miljić, Predrag, Evelien Heylen, Johan Willemse, et al.. (2010). Thrombin activatable fibrinolysis inhibitor (TAFI): A molecular link between coagulation and fibrinolysis. Srpski arhiv za celokupno lekarstvo. 138(suppl. 1). 74–78. 7 indexed citations
9.
Elezović, Ivo. (2010). Acquired haemophilia syndrome: Pathophysiology and therapy. Srpski arhiv za celokupno lekarstvo. 138(suppl. 1). 64–68. 16 indexed citations
10.
Heylen, Evelien, Predrag Miljić, Johan Willemse, et al.. (2009). Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia. Thrombosis Research. 124(4). 427–432. 14 indexed citations
11.
Antić, Darko, et al.. (2008). Right atrial myeloid sarcoma causing superior vena cava syndrome. British Journal of Haematology. 141(2). 134–134. 9 indexed citations
12.
Antić, Darko, et al.. (2008). Spinal epidural granulocytic sarcoma in non-leukemic patient. International Journal of Hematology. 89(1). 95–97. 26 indexed citations
13.
Todorović, Milena, Bela Balint, Nada Suvajdžić, et al.. (2007). Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus “multi-manner” apheresis. Medical Oncology. 25(2). 148–153. 8 indexed citations
14.
Todorović, Milena, Mirjana Pavlović, Bela Balint, et al.. (2007). Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma. Medical Oncology. 24(4). 413–418. 2 indexed citations
15.
Suvajdžić, Nada, Andrija Bogdanović, Vladimir Lazarević, et al.. (2004). Treatment of 36 cases of thrombotic thrombocytopenic purpura. Vojnosanitetski pregled. 61(6). 621–627. 1 indexed citations
16.
Pantić, Milena, Dragomir Marisavljević, Vladimir Djordjević, et al.. (2000). Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence. Medical Oncology. 17(4). 307–313. 26 indexed citations
17.
Μacut, Djuro, Dragan Micić, Nada Suvajdžić, et al.. (2000). Ovulation induction and early pregnancy loss in a woman susceptible to autoimmune diseases: a possible interrelationship. Gynecological Endocrinology. 14(3). 153–157. 5 indexed citations
18.
Suvajdžić, Nada, et al.. (1999). Megakaryocytopoiesis in refractory chronic immune thrombocytopenia. PubMed. 41(4). 163–168. 3 indexed citations
19.
Stajčić, Zoran, et al.. (1989). Primary wound closure in haemophiliacs undergoing dental extractions. International Journal of Oral and Maxillofacial Surgery. 18(1). 14–16. 9 indexed citations
20.
Elezović, Ivo, et al.. (1986). Late thrombosis of the Björk-Shiley tilting disc valve in the tricuspid position. Journal of Thoracic and Cardiovascular Surgery. 91(1). 1–8. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026